CY1110821T1 - Antibakthpiakoi πapaγontες τρικυκλικης tετραϋδροκινολινης - Google Patents

Antibakthpiakoi πapaγontες τρικυκλικης tετραϋδροκινολινης

Info

Publication number
CY1110821T1
CY1110821T1 CY20101100894T CY101100894T CY1110821T1 CY 1110821 T1 CY1110821 T1 CY 1110821T1 CY 20101100894 T CY20101100894 T CY 20101100894T CY 101100894 T CY101100894 T CY 101100894T CY 1110821 T1 CY1110821 T1 CY 1110821T1
Authority
CY
Cyprus
Prior art keywords
tetraydrokinoline
pagagones
antibakthpiakoi
tricyclic
tetrahydroquinoline
Prior art date
Application number
CY20101100894T
Other languages
Greek (el)
English (en)
Inventor
M R Barbachyn
P J Dobrowolski
A R Hurd
D J Mcnamara
John Raymond Palmer
A G Romero
James Craig Ruble
D A Sherry
L M Thomasco
P L Toogood
Gordon L Bundy
Gary E Martin
Donna L Romero
Original Assignee
Pharmacia & Upjohn Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company Llc filed Critical Pharmacia & Upjohn Company Llc
Publication of CY1110821T1 publication Critical patent/CY1110821T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CY20101100894T 2002-10-07 2010-10-06 Antibakthpiakoi πapaγontες τρικυκλικης tετραϋδροκινολινης CY1110821T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41668502P 2002-10-07 2002-10-07
US42718902P 2002-11-18 2002-11-18
US45762203P 2003-03-26 2003-03-26
EP03799056A EP1551849B1 (en) 2002-10-07 2003-10-03 Tricyclic tetrahydroquinoline antibacterial agents

Publications (1)

Publication Number Publication Date
CY1110821T1 true CY1110821T1 (el) 2015-06-10

Family

ID=32074379

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100894T CY1110821T1 (el) 2002-10-07 2010-10-06 Antibakthpiakoi πapaγontες τρικυκλικης tετραϋδροκινολινης

Country Status (16)

Country Link
US (4) US7208490B2 (cg-RX-API-DMAC7.html)
EP (1) EP1551849B1 (cg-RX-API-DMAC7.html)
JP (1) JP4009652B2 (cg-RX-API-DMAC7.html)
AR (1) AR041546A1 (cg-RX-API-DMAC7.html)
AT (1) ATE473985T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003264768A1 (cg-RX-API-DMAC7.html)
BR (1) BR0315139A (cg-RX-API-DMAC7.html)
CA (1) CA2500824C (cg-RX-API-DMAC7.html)
CY (1) CY1110821T1 (cg-RX-API-DMAC7.html)
DE (1) DE60333379D1 (cg-RX-API-DMAC7.html)
DK (1) DK1551849T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA05002701A (cg-RX-API-DMAC7.html)
PT (1) PT1551849E (cg-RX-API-DMAC7.html)
SI (1) SI1551849T1 (cg-RX-API-DMAC7.html)
TW (1) TWI295671B (cg-RX-API-DMAC7.html)
WO (1) WO2004031195A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
CA2606847A1 (en) * 2005-05-09 2006-11-16 Warner-Lambert Company Llc Antibacterial agents
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
RU2010103101A (ru) * 2007-07-02 2011-08-10 Астразенека Аб (Se) Химические соединения
US20110178064A1 (en) 2007-07-16 2011-07-21 Astrazeneca R&D Spiro condensed barbituric acid derivatives for use as antibacterial
TW201020258A (en) * 2008-10-14 2010-06-01 Astrazeneca Ab Chemical compounds 542
US9040528B2 (en) 2008-10-14 2015-05-26 Astrazeneca Ab Chemical compounds 542
RU2505539C2 (ru) * 2008-12-23 2014-01-27 Эбботт Лэборетриз Антивирусные соединения
NZ705225A (en) 2010-07-16 2016-11-25 Abbvie Bahamas Ltd Process for preparing antiviral compounds
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
US8841487B2 (en) 2010-07-16 2014-09-23 Abbvie Inc. Phosphine ligands for catalytic reactions
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
WO2014042647A1 (en) * 2012-09-14 2014-03-20 Levina Elizabeth Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi
US8952149B2 (en) 2012-09-26 2015-02-10 Zoetis Llc Tricyclic tetrahydroquinoline antibacterial agents
US8889671B2 (en) 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections
JP6156845B2 (ja) * 2014-03-04 2017-07-05 株式会社島津製作所 マトリックス支援レーザ脱離イオン化質量分析用マトリックス
SG11201609404SA (en) 2014-05-29 2016-12-29 Entasis Therapeutics Ltd Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
US10995097B2 (en) * 2016-03-11 2021-05-04 The Board Of Trustees Of The University Of Illinois Small molecules active against gram-negative bacteria
US11274106B2 (en) 2017-06-23 2022-03-15 The Board Of Trustees Of The University Of Illinois Topoisomerase inhibitors with antibacterial and anticancer activity
CN108101860B (zh) * 2018-02-08 2021-11-23 苏州敬业医药化工有限公司 顺式-2,6-二甲基吗啉的制备方法
CN115466212B (zh) * 2022-10-26 2023-09-22 河南农业大学 一种2-三氟甲基喹啉类化合物及其合成方法和应用
CN118878546B (zh) * 2024-09-30 2025-01-03 苏州大学 一种螺环巴比妥酸衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011860A (en) 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
DE19502178A1 (de) 1994-01-27 1995-08-03 Hoechst Ag Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen
CZ20031083A3 (cs) 2000-10-26 2004-03-17 Pfizer Products Inc. 5-Spiropyrimidin-2, 4, 6-trionové inhibitory metaloproteinasy
AU2003228701A1 (en) 2002-04-25 2003-11-10 Bristol-Myers Squibb Company Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
WO2004033449A1 (en) 2002-10-10 2004-04-22 Pharmacia & Upjohn Company Llc Antimicrobial 1-aryl dihydropyridone compounds

Also Published As

Publication number Publication date
PT1551849E (pt) 2010-09-27
ATE473985T1 (de) 2010-07-15
CA2500824C (en) 2011-03-22
JP2006511595A (ja) 2006-04-06
US20110092494A1 (en) 2011-04-21
TWI295671B (en) 2008-04-11
US7605157B2 (en) 2009-10-20
TW200413394A (en) 2004-08-01
BR0315139A (pt) 2005-08-09
WO2004031195A1 (en) 2004-04-15
JP4009652B2 (ja) 2007-11-21
EP1551849B1 (en) 2010-07-14
SI1551849T1 (sl) 2010-11-30
US7208490B2 (en) 2007-04-24
DK1551849T3 (da) 2010-10-25
DE60333379D1 (de) 2010-08-26
US8420646B2 (en) 2013-04-16
US20070161630A1 (en) 2007-07-12
US20100022524A1 (en) 2010-01-28
CA2500824A1 (en) 2004-04-15
MXPA05002701A (es) 2005-08-19
US20040162279A1 (en) 2004-08-19
AU2003264768A1 (en) 2004-04-23
AR041546A1 (es) 2005-05-18
EP1551849A1 (en) 2005-07-13

Similar Documents

Publication Publication Date Title
CY1116784T1 (el) Αντιμικροβιακες ενωσεις και μεθοδοι για χρηση αυτων
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
CY1112630T1 (el) Αναστολεις πυριδυλιου της σηματοδοτησης hedgehog
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
CY1107503T1 (el) Αντιβιοτικα διπλης δρασης
CY1108843T1 (el) 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων
SE0302811D0 (sv) Novel compounds
CY1109422T1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
BR0315139A (pt) Agentes antibacterianos de tetraidroquinolina tricìclica
CY1114008T1 (el) Θειενοπυριμιδινικες ενωσεις και χρηση τους
CY1108729T1 (el) 3,11b-cis-διυδpotetpabenazinh για την θεραπευτικη αντιμετωπιση μιας πολλαπλασιαστικης νοσου ή φλεγμονωδους παθησης
ATE433447T1 (de) Pyrimiidinverbindungen
CY1119488T1 (el) Παραγων για θεραπεια ή/και αποτροπη διαταραχης υπνου
CY1111143T1 (el) Καινοφανη παραγωγα κυανοπυριδινης χρησιμα στην αντιμετωπιση καρκινου και αλλων διαταραχων
NO20051082L (no) Antimikrobielle kinoloner, deres sammensetninger og anvendelser
CY1122429T1 (el) Αμορφη υδροχλωρικη λερκανιδιπινη
CY1110398T1 (el) Ενωσεις για την αγωγη της δυσλιπιδαιμιας
CY1115580T1 (el) Συνθεση και αντι-ιικη δραστηριοτητα των υποκατεστημενων παραγωγων αζαϊνδολοοξικης πιπεραζινης
CY1105705T1 (el) Παραγωγα ινδολυλαλκυλαμινης σαν συνδετηρες 5-υδροξυτρυπταμινης-6
CY1111613T1 (el) Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
ATE413388T1 (de) Muskarin antagonisten
CY1105362T1 (el) Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
CY1111567T1 (el) Ενδιαμεσα διβενζο (b,f) αζεπινης
ECSP044999A (es) Agentes antidiabeticos